SnagRx Review
Best for: compounded semaglutide and tirzepatide at a flat lifetime price
SnagRx is a cash-pay GLP-1 telehealth service from Modern Metabolic Medicine, Inc. offering compounded semaglutide and compounded tirzepatide shipped to your door in 1-2 days. Pricing is flat for life at the same price every dose, with a launch discount taking semaglutide to $99/mo and tirzepatide to $149/mo. No insurance, no membership; telehealth visit and shipping included.
then $299/mo ongoing
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
SnagRx is a solid telehealth option with balanced features and pricing.
SnagRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $99/mo ($299/mo struck through to $99/mo Summer Start Discount verified on snagrx.com 2026-06-19; flat same price every dose)
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored SnagRx
Each dimension is scored algorithmically from SnagRx’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.7/10At $299/mo, SnagRx runs about 76% above the $170 median for GLP-1 providers, and the first-month promo drops to $99. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.9/10SnagRx offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
8.2/10Online intake and platform experience — consult included in the price; 6 platform features disclosed.
Trust & Safety15%
8.1/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-19).
Accessibility10%
6.9/10SnagRx's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
6.7/10SnagRx provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this SnagRx review
Last checked 2026-06-19- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications SnagRx offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
$299/mo struck through to $99/mo Summer Start Discount verified on snagrx.com 2026-06-19; flat same price every dose
$399/mo struck through to $149/mo Summer Start Discount verified on snagrx.com 2026-06-19; flat per-month pricing
Ready to get started?
Plans and promotions change often — check SnagRx's current pricing and active discounts before you decide.
What we like
- Compounded semaglutide ($99/mo) and tirzepatide ($149/mo) on launch discount, flat-priced at every dose
- Names four partner pharmacies in Terms (RedRock, Health Warehouse, Precision Compounding, Triad Rx)
- Available in all 50 states plus Washington D.C. per Terms
- Telemed visit, prescription and free 1-2 day shipping included; no insurance or membership
- Cancel anytime; full refund if disqualified by the medical provider
Watch-outs
- Headline $99/$149 prices are discounted from $299/$399 standard; a countdown timer pressures signup
- No brand-name Wegovy/Zepbound/Mounjaro/Ozempic - compounded injectable only
- Refunds only available before medication is ordered; all sales otherwise final
- Binding JAMS arbitration under Delaware law; class-action waiver
Is SnagRx worth it? Our verdict
SnagRx positions itself around one thing: compounded semaglutide and tirzepatide at a flat lifetime price. New patients start at $99 in month one, but the price settles at $299/month after that — so the headline is a trial offer, not the standing rate. Its flat, all-dose pricing is a genuine plus for anyone worried about cost climbing as they titrate up.
How much SnagRx actually costs
- Compounded semaglutide — $99 first month, then $299/month
- Compounded tirzepatide — $149 first month, then $399/month
For context, the typical ongoing price across the GLP-1 providers we track is around $170/month, so SnagRx's standing rate sits at the premium end. The first-month discount is a great way to start cheaply, but price out the ongoing rate against a flat-rate provider before you commit long term.
Medications: what SnagRx prescribes
SnagRx prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Who SnagRx is best for — and who should skip it
A good fit if you…
- want the cheapest possible way to start a GLP-1 and see how you respond before committing.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
SnagRx is one of the easiest ways to start a GLP-1 cheaply — just go in clear-eyed that the $99 intro price steps up to $299/month. Use the first month to confirm the medication works for you, then re-check the ongoing math before you settle in.
Ready to start with SnagRx?
Starting at $99/month. See current pricing and start your free consultation.
Alternatives to SnagRx
Editorial score · methodology
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this SnagRx review:
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with SnagRx?
Starting at $99/month. See current pricing and start your free consultation.